2000
DOI: 10.1097/00003246-200002000-00025
|View full text |Cite
|
Sign up to set email alerts
|

Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: A randomized, placebo-controlled, crossover study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
62
0
3

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 98 publications
(66 citation statements)
references
References 56 publications
1
62
0
3
Order By: Relevance
“…In previous studies comparing metoclopramide and erythromycin as a prokinetic agent, erythromycin has been found to be equivalent to metoclopramide [27,28].…”
Section: Discussionmentioning
confidence: 96%
“…In previous studies comparing metoclopramide and erythromycin as a prokinetic agent, erythromycin has been found to be equivalent to metoclopramide [27,28].…”
Section: Discussionmentioning
confidence: 96%
“…This contributes to the insufficient intake of calories and greater postoperative complications, further adding to cost of treatment (10)(11)(12). In order to treat gastric hypo motility and intolerance, pro-motility drugs and small bowel tube feeding were used (13)(14)(15). However, in routine clinical use, bearing in mind economic and rational approach, and also to avoid side effects, pro-motility drugs are exclusively used in treating already existing gastric intolerance but not for the prevention of postoperative gastric hypomotility (13,14).…”
Section: Discussionmentioning
confidence: 99%
“…In order to treat gastric hypo motility and intolerance, pro-motility drugs and small bowel tube feeding were used (13)(14)(15). However, in routine clinical use, bearing in mind economic and rational approach, and also to avoid side effects, pro-motility drugs are exclusively used in treating already existing gastric intolerance but not for the prevention of postoperative gastric hypomotility (13,14). The post-pyloric placement of feeding tube requires certain clinical experience and is technically demanding and time-consuming.…”
Section: Discussionmentioning
confidence: 99%
“…Cisapride is the most well known agent in this class, and has dual stimulatory effects on the 5-Hydroxytryptamine (5-HT4) serotonin receptors and the parasympathetic nervous system, leading to increases in both 5-HT4 and acetylcholine in the enteric nervous system. The use of cisapride has been shown to associate with improved gastric emptying in critically ill patients as well as reduced the occurrence of feed intolerance [38][39][40][41][42] . Due to case reports of cisapride induced lethal cardiac toxicity [43] , however, the drug has been withdrawn and is not available for clinical use.…”
Section: Serotonin (5-hydroxytryptamine) Receptor Agonistsmentioning
confidence: 99%